Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 3330 entries
Sorted by: Best Match Show Resources per page
Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement.

CEN case reports

Nishimura S, Matsumae T, Murakami Y, Abe Y, Sasatomi Y, Nagayoshi I, Ueda K, Nakashima H.
PMID: 28509203
CEN Case Rep. 2014 Nov;3(2):217-222. doi: 10.1007/s13730-014-0121-6. Epub 2014 Apr 16.

A 75-year-old woman was admitted to our hospital because of proteinuria, pitting edema on the foot, and renal impairment. She had undergone total hip replacement (THR) for femoral neck fracture at the age of 66. Nine years later, she...

Cite
Nishimura S, Matsumae T, Murakami Y, et al. Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement. CEN Case Rep. 2014;3(2):217-222doi: 10.1007/s13730-014-0121-6.
Nishimura, S., Matsumae, T., Murakami, Y., Abe, Y., Sasatomi, Y., Nagayoshi, I., Ueda, K., & Nakashima, H. (2014). Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement. CEN case reports, 3(2), 217-222. https://doi.org/10.1007/s13730-014-0121-6
Nishimura, Shinsuke, et al. "Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement." CEN case reports vol. 3,2 (2014): 217-222. doi: https://doi.org/10.1007/s13730-014-0121-6
Nishimura S, Matsumae T, Murakami Y, Abe Y, Sasatomi Y, Nagayoshi I, Ueda K, Nakashima H. Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement. CEN Case Rep. 2014 Nov;3(2):217-222. doi: 10.1007/s13730-014-0121-6. Epub 2014 Apr 16. PMID: 28509203; PMCID: PMC5411571.
Copy Download .nbib Format: NLM
Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review.

Oncology letters

Mokutani Y, Hata T, Miyake Y, Kuroda H, Takahashi H, Haraguchi N, Nishimura J, Mizushima T, Yamamoto H, Doki Y, Mori M.
PMID: 28454464
Oncol Lett. 2017 Apr;13(4):2765-2769. doi: 10.3892/ol.2017.5755. Epub 2017 Feb 21.

Primary hepatic angiosarcoma is a rare type of tumor with a poor prognosis. To the best of our knowledge, curative surgery of a metastatic gastrointestinal angiosarcoma from a hepatic angiosarcoma has not been reported previously. In the present report,...

Cite
Mokutani Y, Hata T, Miyake Y, et al. Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review. Oncol Lett. 2017;13(4):2765-2769doi: 10.3892/ol.2017.5755.
Mokutani, Y., Hata, T., Miyake, Y., Kuroda, H., Takahashi, H., Haraguchi, N., Nishimura, J., Mizushima, T., Yamamoto, H., Doki, Y., & Mori, M. (2017). Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review. Oncology letters, 13(4), 2765-2769. https://doi.org/10.3892/ol.2017.5755
Mokutani, Yukako, et al. "Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review." Oncology letters vol. 13,4 (2017): 2765-2769. doi: https://doi.org/10.3892/ol.2017.5755
Mokutani Y, Hata T, Miyake Y, Kuroda H, Takahashi H, Haraguchi N, Nishimura J, Mizushima T, Yamamoto H, Doki Y, Mori M. Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review. Oncol Lett. 2017 Apr;13(4):2765-2769. doi: 10.3892/ol.2017.5755. Epub 2017 Feb 21. PMID: 28454464; PMCID: PMC5403321.
Copy Download .nbib Format: NLM
Identification of glypican-3-derived long peptides activating both CD8.

Oncoimmunology

Sayem MA, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K, Nakatsura T, Nishimura Y.
PMID: 26942076
Oncoimmunology. 2015 Aug 31;5(1):e1062209. doi: 10.1080/2162402X.2015.1062209. eCollection 2016.

In a recent phase I clinical trial, a vaccine consisting of glypican-3 (GPC3)-derived CTL epitopes was found to be safe and induced measurable immune and clinical responses in patients with hepatocellular carcinoma (HCC). The aim of this study was...

Cite
Sayem MA, Tomita Y, Yuno A, et al. Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology. 2015;5(1):e1062209doi: 10.1080/2162402X.2015.1062209.
Sayem, M. A., Tomita, Y., Yuno, A., Hirayama, M., Irie, A., Tsukamoto, H., Senju, S., Yuba, E., Yoshikawa, T., Kono, K., Nakatsura, T., & Nishimura, Y. (2016). Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology, 5(1), e1062209. https://doi.org/10.1080/2162402X.2015.1062209
Sayem, Mohammad A, et al. "Identification of glypican-3-derived long peptides activating both CD8." Oncoimmunology vol. 5,1 (2016): e1062209. doi: https://doi.org/10.1080/2162402X.2015.1062209
Sayem MA, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K, Nakatsura T, Nishimura Y. Identification of glypican-3-derived long peptides activating both CD8. Oncoimmunology. 2015 Aug 31;5(1):e1062209. doi: 10.1080/2162402X.2015.1062209. eCollection 2016. PMID: 26942076; PMCID: PMC4760284.
Copy Download .nbib Format: NLM
Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report.

Molecular and clinical oncology

Nishimura S, Hashimoto K, Tan A, Yagyu Y, Akagi M.
PMID: 28451403
Mol Clin Oncol. 2017 Mar;6(3):307-310. doi: 10.3892/mco.2017.1137. Epub 2017 Jan 23.

Giant cell tumor of bone (GCTB) is commonly treated with surgery; however, surgery of GCTB in the sacrum may be challenging due to the associated risk. A conservative approach may be selective arterial embolization or zoledronic acid (ZOL) treatment;...

Cite
Nishimura S, Hashimoto K, Tan A, et al. Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report. Mol Clin Oncol. 2017;6(3):307-310doi: 10.3892/mco.2017.1137.
Nishimura, S., Hashimoto, K., Tan, A., Yagyu, Y., & Akagi, M. (2017). Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report. Molecular and clinical oncology, 6(3), 307-310. https://doi.org/10.3892/mco.2017.1137
Nishimura, Shunji, et al. "Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report." Molecular and clinical oncology vol. 6,3 (2017): 307-310. doi: https://doi.org/10.3892/mco.2017.1137
Nishimura S, Hashimoto K, Tan A, Yagyu Y, Akagi M. Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report. Mol Clin Oncol. 2017 Mar;6(3):307-310. doi: 10.3892/mco.2017.1137. Epub 2017 Jan 23. PMID: 28451403; PMCID: PMC5403697.
Copy Download .nbib Format: NLM
[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.

International journal of oncology

Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M.
PMID: 27634111
Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16.

Following the publication of this article, an interested reader drew to our attention an anomaly associated with the presen-tation of the Fig. 2D; specifically, there appeared to have been a duplication of the same β-actin control band for the...

Cite
Yamamoto H, Oshiro R, Ohtsuka M, et al. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2016;49(5):2186doi: 10.3892/ijo.2016.3694.
Yamamoto, H., Oshiro, R., Ohtsuka, M., Uemura, M., Haraguchi, N., Nishimura, J., Takemasa, I., Mizushima, T., Doki, Y., & Mori, M. (2016). [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. International journal of oncology, 49(5), 2186. https://doi.org/10.3892/ijo.2016.3694
Yamamoto, Hirofumi, et al. "[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies." International journal of oncology vol. 49,5 (2016): 2186. doi: https://doi.org/10.3892/ijo.2016.3694
Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16. PMID: 27634111; PMCID: PMC5063454.
Copy Download .nbib Format: NLM
Chronic encapsulated intracerebral hematoma: Three case reports and a literature review.

Surgical neurology international

Nishiyama A, Toi H, Takai H, Hirai S, Yokosuka K, Matsushita N, Hirano K, Matsubara S, Nishimura H, Uno M.
PMID: 25024888
Surg Neurol Int. 2014 Jun 06;5:88. doi: 10.4103/2152-7806.134076. eCollection 2014.

BACKGROUND: Chronic encapsulated intracerebral hematoma (CEIH) is one type of intracerebral hematoma that sometimes grows progressively while forming a capsule and presenting with neurological deficits. Although many cases of CEIH have been reported, correct preoperative diagnosis is very difficult....

Cite
Nishiyama A, Toi H, Takai H, et al. Chronic encapsulated intracerebral hematoma: Three case reports and a literature review. Surg Neurol Int. 2014;5:88doi: 10.4103/2152-7806.134076.
Nishiyama, A., Toi, H., Takai, H., Hirai, S., Yokosuka, K., Matsushita, N., Hirano, K., Matsubara, S., Nishimura, H., & Uno, M. (2014). Chronic encapsulated intracerebral hematoma: Three case reports and a literature review. Surgical neurology international, 588. https://doi.org/10.4103/2152-7806.134076
Nishiyama, Akira, et al. "Chronic encapsulated intracerebral hematoma: Three case reports and a literature review." Surgical neurology international vol. 5 (2014): 88. doi: https://doi.org/10.4103/2152-7806.134076
Nishiyama A, Toi H, Takai H, Hirai S, Yokosuka K, Matsushita N, Hirano K, Matsubara S, Nishimura H, Uno M. Chronic encapsulated intracerebral hematoma: Three case reports and a literature review. Surg Neurol Int. 2014 Jun 06;5:88. doi: 10.4103/2152-7806.134076. eCollection 2014. PMID: 25024888; PMCID: PMC4093747.
Copy Download .nbib Format: NLM
A Facile Method to Modify the Characteristics and Corrosion Behavior of 304 Stainless Steel by Surface Nanostructuring toward Biomedical Applications.

ACS applied materials & interfaces

Thangaraj B, Nellaiappan SN, Kulandaivelu R, Lee MH, Nishimura T.
PMID: 26196218
ACS Appl Mater Interfaces. 2015 Aug 19;7(32):17731-47. doi: 10.1021/acsami.5b03877. Epub 2015 Aug 04.

The study addresses how surface nanostructuring of AISI 304 stainless steel (SS) by surface mechanical attrition treatment (SMAT) influences its characteristic properties and corrosion behavior in Ringer's solution. SMAT of 304 SS induced plastic deformation, enabled surface nanocrystallization, refined...

Cite
Thangaraj B, Nellaiappan SN, Kulandaivelu R, et al. A Facile Method to Modify the Characteristics and Corrosion Behavior of 304 Stainless Steel by Surface Nanostructuring toward Biomedical Applications. ACS Appl Mater Interfaces. 2015;7(32):17731-47doi: 10.1021/acsami.5b03877.
Thangaraj, B., Nellaiappan, S. N., Kulandaivelu, R., Lee, M. H., & Nishimura, T. (2015). A Facile Method to Modify the Characteristics and Corrosion Behavior of 304 Stainless Steel by Surface Nanostructuring toward Biomedical Applications. ACS applied materials & interfaces, 7(32), 17731-47. https://doi.org/10.1021/acsami.5b03877
Thangaraj, Balusamy, et al. "A Facile Method to Modify the Characteristics and Corrosion Behavior of 304 Stainless Steel by Surface Nanostructuring toward Biomedical Applications." ACS applied materials & interfaces vol. 7,32 (2015): 17731-47. doi: https://doi.org/10.1021/acsami.5b03877
Thangaraj B, Nellaiappan SN, Kulandaivelu R, Lee MH, Nishimura T. A Facile Method to Modify the Characteristics and Corrosion Behavior of 304 Stainless Steel by Surface Nanostructuring toward Biomedical Applications. ACS Appl Mater Interfaces. 2015 Aug 19;7(32):17731-47. doi: 10.1021/acsami.5b03877. Epub 2015 Aug 04. PMID: 26196218.
Copy Download .nbib Format: NLM
Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension.

Frontiers in pharmacology

Sasagawa S, Nishimura Y, Sawada H, Zhang E, Okabe S, Murakami S, Ashikawa Y, Yuge M, Kawaguchi K, Kawase R, Mitani Y, Maruyama K, Tanaka T.
PMID: 27375481
Front Pharmacol. 2016 Jun 07;7:142. doi: 10.3389/fphar.2016.00142. eCollection 2016.

Pulmonary arterial hypertension (PAH) is a heterogeneous disorder associated with a progressive increase in pulmonary artery resistance and pressure. Although various therapies have been developed, the 5-year survival rate of PAH patients remains low. There is thus an important...

Cite
Sasagawa S, Nishimura Y, Sawada H, et al. Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension. Front Pharmacol. 2016;7:142doi: 10.3389/fphar.2016.00142.
Sasagawa, S., Nishimura, Y., Sawada, H., Zhang, E., Okabe, S., Murakami, S., Ashikawa, Y., Yuge, M., Kawaguchi, K., Kawase, R., Mitani, Y., Maruyama, K., & Tanaka, T. (2016). Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension. Frontiers in pharmacology, 7142. https://doi.org/10.3389/fphar.2016.00142
Sasagawa, Shota, et al. "Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension." Frontiers in pharmacology vol. 7 (2016): 142. doi: https://doi.org/10.3389/fphar.2016.00142
Sasagawa S, Nishimura Y, Sawada H, Zhang E, Okabe S, Murakami S, Ashikawa Y, Yuge M, Kawaguchi K, Kawase R, Mitani Y, Maruyama K, Tanaka T. Comparative Transcriptome Analysis Identifies CCDC80 as a Novel Gene Associated with Pulmonary Arterial Hypertension. Front Pharmacol. 2016 Jun 07;7:142. doi: 10.3389/fphar.2016.00142. eCollection 2016. PMID: 27375481; PMCID: PMC4894905.
Copy Download .nbib Format: NLM
Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report.

Multidisciplinary respiratory medicine

Suzuki S, Nishimura N, Jinta T, Yamano Y, Ishikawa G, Tomishima Y, Uchiyama N, Chohnabayashi N.
PMID: 27326370
Multidiscip Respir Med. 2016 Jun 20;11:25. doi: 10.1186/s40248-016-0060-5. eCollection 2016.

BACKGROUND: Early identification and control of pathogenic bacteria are important in the treatment of pneumonia. Currently, two rapid antigen detection kits for pneumococcal pneumonia are available: one uses urine samples and the other, named RAPIRUN® S. pneumoniae, uses sputum...

Cite
Suzuki S, Nishimura N, Jinta T, et al. Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report. Multidiscip Respir Med. 2016;11:25doi: 10.1186/s40248-016-0060-5.
Suzuki, S., Nishimura, N., Jinta, T., Yamano, Y., Ishikawa, G., Tomishima, Y., Uchiyama, N., & Chohnabayashi, N. (2016). Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report. Multidisciplinary respiratory medicine, 1125. https://doi.org/10.1186/s40248-016-0060-5
Suzuki, Shoji, et al. "Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report." Multidisciplinary respiratory medicine vol. 11 (2016): 25. doi: https://doi.org/10.1186/s40248-016-0060-5
Suzuki S, Nishimura N, Jinta T, Yamano Y, Ishikawa G, Tomishima Y, Uchiyama N, Chohnabayashi N. Evaluation of the rapid immunochromatographic ODK0501 assay for Streptococcus pneumoniae antigen detection with nasopharyngeal swabs: preliminary report. Multidiscip Respir Med. 2016 Jun 20;11:25. doi: 10.1186/s40248-016-0060-5. eCollection 2016. PMID: 27326370; PMCID: PMC4913422.
Copy Download .nbib Format: NLM
Endovascular Treatment of Left Subclavian Artery Pseudoaneurysm after Clavicle Fracture in an Elderly Adult with a 40-Year History of Behçet's Disease.

Annals of vascular diseases

Nishimura K, Hamasaki T, Yamamoto S, Kawai T, Sugiura K.
PMID: 26730261
Ann Vasc Dis. 2015;8(4):328-30. doi: 10.3400/avd.cr.15-00082. Epub 2015 Oct 15.

Behçet's disease (BD) is a rare chronic systemic vasculitis of unknown etiology that presents in young adults. We report a very rare case of a left subclavian artery pseudoaneurysm identified after a left clavicle fracture in a 70-year-old man...

Cite
Nishimura K, Hamasaki T, Yamamoto S, et al. Endovascular Treatment of Left Subclavian Artery Pseudoaneurysm after Clavicle Fracture in an Elderly Adult with a 40-Year History of Behçet's Disease. Ann Vasc Dis. 2015;8(4):328-30doi: 10.3400/avd.cr.15-00082.
Nishimura, K., Hamasaki, T., Yamamoto, S., Kawai, T., & Sugiura, K. (2015). Endovascular Treatment of Left Subclavian Artery Pseudoaneurysm after Clavicle Fracture in an Elderly Adult with a 40-Year History of Behçet's Disease. Annals of vascular diseases, 8(4), 328-30. https://doi.org/10.3400/avd.cr.15-00082
Nishimura, Kengo, et al. "Endovascular Treatment of Left Subclavian Artery Pseudoaneurysm after Clavicle Fracture in an Elderly Adult with a 40-Year History of Behçet's Disease." Annals of vascular diseases vol. 8,4 (2015): 328-30. doi: https://doi.org/10.3400/avd.cr.15-00082
Nishimura K, Hamasaki T, Yamamoto S, Kawai T, Sugiura K. Endovascular Treatment of Left Subclavian Artery Pseudoaneurysm after Clavicle Fracture in an Elderly Adult with a 40-Year History of Behçet's Disease. Ann Vasc Dis. 2015;8(4):328-30. doi: 10.3400/avd.cr.15-00082. Epub 2015 Oct 15. PMID: 26730261; PMCID: PMC4691510.
Copy Download .nbib Format: NLM
Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure.

Journal of traditional and complementary medicine

Nishimura M, Yoshida S, Haramoto M, Mizuno H, Fukuda T, Kagami-Katsuyama H, Tanaka A, Ohkawara T, Sato Y, Nishihira J.
PMID: 26870683
J Tradit Complement Med. 2015 Jan 08;6(1):66-71. doi: 10.1016/j.jtcme.2014.11.022. eCollection 2016 Jan.

Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter with beneficial effects including antihypertension and antistress properties. In this study, we examined the effects of GABA-enriched white rice (GABA rice) on blood pressure (BP) in 39 mildly hypertensive adults in a...

Cite
Nishimura M, Yoshida S, Haramoto M, et al. Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure. J Tradit Complement Med. 2015;6(1):66-71doi: 10.1016/j.jtcme.2014.11.022.
Nishimura, M., Yoshida, S., Haramoto, M., Mizuno, H., Fukuda, T., Kagami-Katsuyama, H., Tanaka, A., Ohkawara, T., Sato, Y., & Nishihira, J. (2016). Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure. Journal of traditional and complementary medicine, 6(1), 66-71. https://doi.org/10.1016/j.jtcme.2014.11.022
Nishimura, Mie, et al. "Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure." Journal of traditional and complementary medicine vol. 6,1 (2016): 66-71. doi: https://doi.org/10.1016/j.jtcme.2014.11.022
Nishimura M, Yoshida S, Haramoto M, Mizuno H, Fukuda T, Kagami-Katsuyama H, Tanaka A, Ohkawara T, Sato Y, Nishihira J. Effects of white rice containing enriched gamma-aminobutyric acid on blood pressure. J Tradit Complement Med. 2015 Jan 08;6(1):66-71. doi: 10.1016/j.jtcme.2014.11.022. eCollection 2016 Jan. PMID: 26870683; PMCID: PMC4738072.
Copy Download .nbib Format: NLM
[Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma.

Oncology reports

Sano D, Kawakami M, Fujita K, Kimura M, Yamashita Y, Ishiguro Y, Nishimura G, Matsuda H, Tsukuda M.
PMID: 26781072
Oncol Rep. 2016 Apr;35(4):2495. doi: 10.3892/or.2016.4574. Epub 2016 Jan 18.

Oncol Rep 17: [Related article:] 289–295, 2007; DOI: 10.3892/or.17.2.289 After the publication of the article, the authors noted that the relevance of the findings reported in this article on ZD6474 inhibition of growth of head and neck squamous cell...

Cite
Sano D, Kawakami M, Fujita K, et al. [Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncol Rep. 2016;35(4):2495doi: 10.3892/or.2016.4574.
Sano, D., Kawakami, M., Fujita, K., Kimura, M., Yamashita, Y., Ishiguro, Y., Nishimura, G., Matsuda, H., & Tsukuda, M. (2016). [Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncology reports, 35(4), 2495. https://doi.org/10.3892/or.2016.4574
Sano, Daisuke, et al. "[Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma." Oncology reports vol. 35,4 (2016): 2495. doi: https://doi.org/10.3892/or.2016.4574
Sano D, Kawakami M, Fujita K, Kimura M, Yamashita Y, Ishiguro Y, Nishimura G, Matsuda H, Tsukuda M. [Corrigendum] Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncol Rep. 2016 Apr;35(4):2495. doi: 10.3892/or.2016.4574. Epub 2016 Jan 18. PMID: 26781072.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 3330 entries